Philip D Harvey Selected Research

HDL Lipoproteins

10/2020

Association of C-reactive protein and metabolic risk with cognitive effects of lurasidone in patients with schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip D Harvey Research Topics

Disease

79	Schizophrenia (Dementia Praecox) 11/2023 - 03/2002
16	Psychotic Disorders (Schizoaffective Disorder) 05/2024 - 09/2003
13	Cognitive Dysfunction 09/2022 - 03/2002
11	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 07/2021 - 05/2005
9	Bipolar Disorder (Manic Depressive Psychosis) 12/2018 - 11/2005
7	Schizotypal Personality Disorder 01/2019 - 05/2003
6	Mental Disorders (Mental Disorder) 01/2022 - 05/2010
5	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 08/2016
4	Neurobehavioral Manifestations 01/2020 - 06/2006
4	Weight Gain 01/2020 - 02/2005
3	Alzheimer Disease (Alzheimer's Disease) 09/2022 - 01/2018
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 02/2009
2	Inflammation (Inflammations) 10/2020 - 08/2016
2	Hypertension (High Blood Pressure) 04/2020 - 08/2015
2	Hypotension (Low Blood Pressure) 01/2019 - 01/2015
2	Sleepiness 09/2016 - 08/2007
2	Disorders of Excessive Somnolence (Hypersomnia) 09/2016 - 04/2014
2	Personality Disorders (Personality Disorder) 12/2013 - 12/2007
2	Dementia (Dementias) 01/2010 - 10/2005
2	Mania (Manias) 12/2008 - 11/2005
1	Amphetamine-Related Disorders (Addiction, Amphetamine) 01/2023
1	COVID-19 01/2023
1	Autism Spectrum Disorder 10/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Insulin Resistance 10/2020
1	Psychomotor Agitation (Akathisia) 01/2020
1	Orthostatic Hypotension (Postural Hypotension) 01/2020
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2018
1	Autistic Disorder (Autism) 12/2018
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2018
1	Treatment-Resistant Schizophrenia 10/2016
1	Overweight 09/2015
1	Brain Neoplasms (Brain Tumor) 05/2015
1	Dizziness (Lightheadedness) 01/2015
1	Body Weight (Weight, Body) 01/2015
1	Tachycardia (Tachyarrhythmias) 01/2015

Drug/Important Bio-Agent (IBA)

32	Antipsychotic Agents (Antipsychotics)IBA 01/2023 - 01/2003
13	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2020 - 03/2002
13	ziprasidone (Geodon)FDA Link 04/2011 - 02/2004
10	Quetiapine Fumarate (Seroquel)FDA Link 10/2020 - 11/2006
9	Lurasidone Hydrochloride FDA Link 10/2020 - 02/2011
7	Haloperidol (Haldol)FDA LinkGeneric 01/2019 - 05/2005
7	Olanzapine (Zyprexa)FDA Link 06/2007 - 09/2003
6	Silver Sulfadiazine (SSD)FDA LinkGeneric 11/2023 - 02/2006
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2014
5	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2010 - 08/2005
4	roluperidoneIBA 01/2022 - 05/2018
4	VortioxetineIBA 07/2021 - 04/2017
4	Antidepressive Agents (Antidepressants)IBA 01/2021 - 02/2005
4	Dopamine (Intropin)FDA LinkGeneric 05/2018 - 12/2007
4	LipidsIBA 01/2018 - 02/2005
4	Clozapine (Clozaril)FDA LinkGeneric 10/2016 - 10/2008
3	Glutamic Acid (Glutamate)FDA Link 01/2023 - 03/2009
3	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 02/2005
3	GlucocorticoidsIBA 01/2009 - 08/2007
2	Rivastigmine (Exelon)FDA LinkGeneric 01/2021 - 02/2009
2	ProlactinIBA 01/2020 - 01/2019
2	blonanserinIBA 01/2020 - 01/2019
2	Guanfacine (Tenex)FDA LinkGeneric 01/2019 - 05/2007
2	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 06/2018 - 06/2014
2	NBI 77860IBA 06/2018 - 06/2014
2	Dopamine Agonists (Dopamine Agonist)IBA 01/2015 - 05/2010
2	fexofenadine (Allegra)FDA LinkGeneric 08/2008 - 05/2003
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 12/2007 - 06/2006
1	Flavin-Adenine Dinucleotide (FAD)IBA 05/2024
1	Parathyroid Hormone (Parathormone)IBA 01/2023
1	Oxytocin (Pitocin)FDA LinkGeneric 02/2022
1	Messenger RNA (mRNA)IBA 01/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021
1	C-Reactive ProteinIBA 10/2020
1	HDL LipoproteinsIBA 10/2020
1	arabinoxylanIBA 04/2020
1	Glycine Plasma Membrane Transport ProteinsIBA 04/2020
1	BI 425809IBA 04/2020
1	volinanserinIBA 01/2020
1	RitanserinIBA 01/2020
1	Serotonin ReceptorsIBA 01/2020
1	lumateperoneIBA 01/2020
1	pimavanserinIBA 01/2020
1	Estrogens (Estrogen)FDA Link 12/2018
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 04/2017
1	LevomilnacipranIBA 01/2017
1	Nicotine FDA Link 02/2015
1	N- (7- chloro- N- quinuclidin- 3- yl)benzo(b)thiophene- 2- carboxamideIBA 02/2015
1	A-factor (Streptomyces)IBA 01/2015
1	dihydrexidineIBA 01/2015
1	Saline SolutionIBA 01/2015

Therapy/Procedure

9	Therapeutics 04/2020 - 05/2003
3	Institutionalization (Institutionalized Persons) 01/2018 - 05/2013
2	Activities of Daily Living (ADL) 09/2022 - 10/2005
2	Ambulatory Care (Outpatient Care) 03/2014 - 09/2004
2	Aftercare (After-Treatment) 12/2008 - 02/2005
1	Injections 01/2023
1	Precision Medicine 07/2021
1	Transdermal Patch 01/2021
1	Art Therapy 04/2020
1	Drug Therapy (Chemotherapy) 04/2020
1	Cognitive Training 04/2020
1	Long-Term Care 01/2018
1	Resistance Training 09/2015